Home › Asset managers › Brinker Capital Destinations Trust › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Brinker Capital Destinations Trust voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
3,869 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Brinker Capital Destinations Trust voted | Funds |
|---|---|---|---|---|---|---|
| 374WATER INC. | 2025-06-11 | Approval and adoption of the amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock of the Company from 200,000,000 shares to 1,000,000,000 shares. | Capital Structure | Board | AGAINST | 1 |
| 374WATER INC. | 2025-06-11 | Approval of certain amendments to the Company's 2021 Equity Incentive Plan to (i) increase the amount of authorized common stock of the Company issuable under the 2021 Equity Incentive Plan by 12,150,000 shares and (ii) increase the individual non-employee director compensation limit to $300,000 in any calendar year. | Compensation | Board | AGAINST | 1 |
| 3D SYSTEMS CORP. | 2024-08-30 | The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. | Director Elections | Board | AGAINST | 1 |
| 3D SYSTEMS CORP. | 2024-08-30 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson | Director Elections | Board | AGAINST | 1 |
| 3D SYSTEMS CORP. | 2024-08-30 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan | Director Elections | Board | AGAINST | 1 |
| 3D SYSTEMS CORP. | 2025-05-16 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton | Director Elections | Board | AGAINST | 1 |
| 3M CO. | 2025-05-13 | To ratify the appointment of PricewaterhouseCoopers LLP as 3M's independent registered public accounting firm. | Audit-related | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt 2025 Share Award Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt 2025 Share Option Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt Scheme Mandate Limit (New Shares Share Award) under the 2025 Share Award Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt Scheme Mandate Limit (Share Award) under the 2025 Share Award Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt Scheme Mandate Limit (Share Option) under the 2025 Share Option Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt Service Provider Sub-limit (New Shares Share Award) under the 2025 Share Award Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Adopt Service Provider Sub-limit (Share Option) under the 2025 Share Option Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Approve Termination of the 2019 Share Award Scheme | Compensation | Board | AGAINST | 1 |
| 3SBIO INC. | 2025-06-25 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 |
| 89BIO INC. | 2025-05-28 | Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| 8X8 INC. | 2024-08-15 | To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. | Compensation | Board | AGAINST | 1 |
| A.P. MOLLER-MAERSK A/S | 2025-03-18 | Reelect Marc Engel as Director | Director Elections | Board | ABSTAIN | 1 |
| AAC TECHNOLOGIES HOLDINGS INC. | 2025-05-22 | Amend Share Award Scheme and Adopt Scheme After Such Amendments | Compensation | Board | AGAINST | 1 |
| AAC TECHNOLOGIES HOLDINGS INC. | 2025-05-22 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 1 |
| AAC TECHNOLOGIES HOLDINGS INC. | 2025-05-22 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 1 |
| AAON INC. | 2025-05-13 | Election of Directors for a term ending in 2028: A.H. McElroy, II | Director Elections | Board | AGAINST | 1 |
| AAR CORP. | 2024-09-17 | Election of three directors named in the proxy statement: Michael R. Boyce | Director Elections | Board | AGAINST | 1 |
| ABBOTT LABORATORIES | 2025-04-25 | Election of Directors: J. G. Stratton | Director Elections | Board | AGAINST | 1 |
| ABC-MART INC. | 2025-05-27 | Elect Director Noguchi, Minoru | Director Elections | Board | AGAINST | 1 |
| ABC-MART INC. | 2025-05-27 | Elect Director and Audit Committee Member Kobayakawa, Hideki | Director Elections | Board | AGAINST | 1 |
| ACADIA HEALTHCARE COMPANY INC. | 2025-05-29 | Election of Directors: Reeve B. Waud | Director Elections | Board | AGAINST | 1 |
| ACCIONA SA | 2025-06-25 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 1 |
| ACCIONA SA | 2025-06-25 | Approve Remuneration Policy | Compensation | Board | AGAINST | 1 |
| ACCIONA SA | 2025-06-25 | Reelect Carlo Clavarino as Director | Director Elections | Board | AGAINST | 1 |
| ACCIONA SA | 2025-06-25 | Reelect Maite Arango Garcia-Urtiaga as Director | Director Elections | Board | AGAINST | 1 |
| ACCO BRANDS CORP. | 2025-05-20 | Approval of an amendment to the 2022 ACCO Brands Corporation Incentive Plan to increase the number of shares reserved for issuance. | Compensation | Board | AGAINST | 1 |
| ACCOLADE INC. | 2024-08-06 | Election of Directors: Michael Hilton | Director Elections | Board | ABSTAIN | 1 |
| ACCOR SA | 2025-05-28 | Approve Compensation of Sebastien Bazin, Chairman and CEO | Compensation | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Asma Abdulrahman Al-Khulaifi as Director | Director Elections | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Isabelle Simon as Director | Director Elections | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Nicolas Sarkozy as Director | Director Elections | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Qionger Jiang as Director | Director Elections | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Sarmad Zok as Director | Director Elections | Board | AGAINST | 1 |
| ACCOR SA | 2025-05-28 | Reelect Ugo Arzani as Director | Director Elections | Board | AGAINST | 1 |
| ACCURAY INC. | 2024-11-21 | To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan. | Compensation | Board | AGAINST | 1 |
| ACHIEVE LIFE SCIENCES INC. | 2025-06-04 | To approve an amendment to our 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance thereunder. | Compensation | Board | AGAINST | 1 |
| ACKERMANS & VAN HAAREN NV | 2025-05-26 | Reelect Frederic van Haaren as Director | Director Elections | Board | AGAINST | 1 |
| ACKERMANS & VAN HAAREN NV | 2025-05-26 | Reelect Jacques Delen as Director | Director Elections | Board | AGAINST | 1 |
| ACKERMANS & VAN HAAREN NV | 2025-05-26 | Reelect Luc Bertrand as Director | Director Elections | Board | AGAINST | 1 |
| ACM RESEARCH INC. | 2025-06-12 | Election of Directors: Haiping Dun | Director Elections | Board | ABSTAIN | 1 |
| ACOM CO. LTD. | 2025-06-20 | Elect Director Kinoshita, Shigeyoshi | Director Elections | Board | AGAINST | 1 |
| ACOM CO. LTD. | 2025-06-20 | Elect Director and Audit Committee Member Akiyama, Takuji | Director Elections | Board | AGAINST | 1 |
| ACOM CO. LTD. | 2025-06-20 | Elect Director and Audit Committee Member Kiyoka, Akihiro | Director Elections | Board | AGAINST | 1 |
| ACRIVON THERAPEUTICS INC. | 2025-06-13 | Election of Class III Directors: Santhosh Palani, Ph.D., C.F.A. | Director Elections | Board | ABSTAIN | 1 |
| ACUSHNET HOLDINGS CORP. | 2025-06-02 | Election of the following nominees for director: Ho Yeon (Aaron) Lee | Director Elections | Board | ABSTAIN | 1 |
| ACUSHNET HOLDINGS CORP. | 2025-06-02 | Election of the following nominees for director: Keun Chang (Kevin) Yoon | Director Elections | Board | ABSTAIN | 1 |
| ACUSHNET HOLDINGS CORP. | 2025-06-02 | Election of the following nominees for director: Yoon Soo (Gene) Yoon | Director Elections | Board | ABSTAIN | 1 |
| ACV AUCTIONS INC. | 2025-05-28 | Elect two Class I directors: George Chamoun | Director Elections | Board | ABSTAIN | 1 |
| ACV AUCTIONS INC. | 2025-05-28 | Elect two Class I directors: Robert P. Goodman | Director Elections | Board | ABSTAIN | 1 |
| ADAPTIVE BIOTECHNOLOGIES CORP. | 2025-06-10 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders: Chad Robins | Director Elections | Board | ABSTAIN | 1 |
| ADC THERAPEUTICS SA | 2024-11-11 | Approving amendments to Article 4a of the articles of association to increase the Company's capital range The Board of Directors proposes that the amendments to Article 4a of the articles of association to increase the Company's capital range be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC THERAPEUTICS SA | 2024-11-11 | Approving amendments to Article 4c of the articles of association to Increase the Company's conditional share capital for financing, acquisitions and other purposes The Board of Directors proposes that the amendments to Article 4c of the articles of association to increase the Company's conditional share capital for financing, acquisitions and other purposes be approved. | Capital Structure | Board | AGAINST | 1 |
| ADC THERAPEUTICS SA | 2025-06-03 | Approving amendments to article 4b of the articles of association to increase the Company's conditional share capital for employee participation The Board of Directors is proposing that the amendments to article 4b paragraph 1 of the articles of association to increase the Company's conditional share capital for employee participation from 9,547,482 common shares (CHF 763,798.56) to 12,776,259 common shares (CHF 1,022,100.72) be approved, as follows (amendment underlined for ease of reference): "The share capital may be increased in an amount not to exceed CHF 1,022,100.72 through the issuance of up to 12,776,259 fully paid in registered shares with a par value of CHF 0.08 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares, which were granted to or imposed on members of the Board of Directors, members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies." | Capital Structure | Board | AGAINST | 1 |
| ADC THERAPEUTICS SA | 2025-06-03 | Approving an amendment to increase the number of shares authorized under the 2019 Equity Incentive Plan The Board of Directors is proposing that an amendment to increase the number of shares authorized under 2019 Equity Incentive Plan be approved. | Compensation | Board | AGAINST | 1 |
| ADC THERAPEUTICS SA | 2025-06-03 | Approving, on a binding basis under Swiss law, the compensation of the Board of Directors and the Executive Committee The Board of Directors proposes that the maximum aggregate amount of compensation for the members of the Board of Directors for the period between the Annual Meeting and the 2026 annual general meeting of Shareholders be set at $2,300,000. | Compensation | Board | AGAINST | 1 |
| ADMA BIOLOGICS INC. | 2025-06-04 | To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S. | Director Elections | Board | ABSTAIN | 1 |
| ADVANCE AUTO PARTS INC. | 2025-05-14 | Election of the nine directors listed below: Jeffrey J. Jones II | Director Elections | Board | AGAINST | 1 |
| ADVANCED DRAINAGE SYSTEMS INC. | 2024-07-18 | Election of Directors: Alexander R. Fischer | Director Elections | Board | AGAINST | 1 |
| ADVANTEST CORP. | 2025-06-27 | Elect Director and Audit Committee Member Kurita, Yuichi | Director Elections | Board | AGAINST | 1 |
| ADVERUM BIOTECHNOLOGIES INC. | 2025-06-17 | Election of Class II Directors: Patrick Machado | Director Elections | Board | ABSTAIN | 1 |
| ADVERUM BIOTECHNOLOGIES INC. | 2025-06-17 | To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 1 |
| ADVERUM BIOTECHNOLOGIES INC. | 2025-06-17 | To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. | Compensation | Board | AGAINST | 1 |
| AECOM | 2025-02-28 | Election of Directors: Kristy Pipes | Director Elections | Board | AGAINST | 1 |
| AENA S.M.E. SA | 2025-04-09 | Reelect Francisco Javier Marin San Andres as Director | Director Elections | Board | AGAINST | 1 |
| AEON CO. LTD. | 2025-05-28 | Elect Director Okada, Motoya | Director Elections | Board | AGAINST | 1 |
| AEON CO. LTD. | 2025-05-28 | Elect Director Tsukamoto, Takashi | Director Elections | Board | AGAINST | 1 |
| AEON FINANCIAL SERVICE CO. LTD. | 2025-05-23 | Appoint Statutory Auditor Tani, Shinichiro | Compensation | Board | AGAINST | 1 |
| AEON MALL CO. LTD. | 2025-05-22 | Approve Share Exchange Agreement with AEON Co., Ltd | Extraordinary Transactions | Board | AGAINST | 1 |
| AEON MALL CO. LTD. | 2025-05-22 | Elect Director Fujiki, Mitsuhiro | Director Elections | Board | AGAINST | 1 |
| AEON MALL CO. LTD. | 2025-05-22 | Elect Director Ono, Keiji | Director Elections | Board | AGAINST | 1 |
| AEROPORTS DE PARIS ADP | 2025-05-15 | Ratify Appointment of Philippe Pascal as Director | Director Elections | Board | AGAINST | 1 |
| AEROVATE THERAPEUTICS INC. | 2025-04-16 | To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); | Compensation | Board | AGAINST | 1 |
| AEROVATE THERAPEUTICS INC. | 2025-04-16 | To approve the redomestication of Aerovate from the State of Delaware to the State of Nevada by conversion (the "Redomestication Proposal" or "Proposal No. 4"); | Extraordinary Transactions | Board | AGAINST | 1 |
| AEROVIRONMENT INC. | 2024-09-27 | To elect the board of directors' three nominees as directors: Cindy Lewis | Director Elections | Board | AGAINST | 1 |
| AEVA TECHNOLOGIES INC. | 2025-06-20 | Election of Class I Directors: Stefan Sommer, Ph. D. | Director Elections | Board | ABSTAIN | 1 |
| AG MORTGAGE INVESTMENT TRUST INC. | 2025-05-05 | Election of Directors: Nicholas Smith | Director Elections | Board | ABSTAIN | 1 |
| AGCO CORP. | 2025-04-24 | Election of Directors: Michael C. Arnold | Director Elections | Board | AGAINST | 1 |
| AGENUS INC. | 2025-06-17 | To approve a one-time exchange modification of options to purchase shares under our 2019 EIP, our Amended and Restated 2009 Equity Incentive Plan, and our 2015 Inducement Equity Plan. | Compensation | Board | AGAINST | 1 |
| AGENUS INC. | 2025-06-17 | To approve an amendment to our Amended and Restated 2019 Equity Incentive Plan ("2019 EIP") to increase the number of shares of common stock authorized for issuance thereunder from 5,050,000 shares to 12,050,000 shares. | Compensation | Board | AGAINST | 1 |
| AGENUS INC. | 2025-06-17 | To elect Brian Corvese and Timothy Wright as Class I directors, for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Brian Corvese | Director Elections | Board | ABSTAIN | 1 |
| AGILYSYS INC. | 2024-09-12 | Election of Directors: Michael A. Kaufman | Director Elections | Board | ABSTAIN | 1 |
| AGIOS PHARMACEUTICALS INC. | 2025-06-18 | To elect each of the two Class III director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Jacqualyn A. Fouse, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| AGREE REALTY CORP. | 2025-05-15 | Election of Directors: Gregory Lehmkuhl | Director Elections | Board | ABSTAIN | 1 |
| AIA GROUP LTD. | 2025-05-23 | Elect George YEO Yong-Boon | Director Elections | Board | AGAINST | 1 |
| AIA GROUP LTD. | 2025-05-23 | Elect Lawrence LAU Juen-Yee | Director Elections | Board | AGAINST | 1 |
| AIA GROUP LTD. | 2025-05-23 | Elect Narongchai Akrasanee | Director Elections | Board | AGAINST | 1 |
| AIB GROUP PLC | 2025-05-01 | Elect Philip Hobbs, a Shareholder Nominee, as a Director | Director Elections | Board | AGAINST | 1 |
| AIR PRODUCTS AND CHEMICALS INC. | 2025-01-23 | Election of Directors: Mantle Ridge Nominees OPPOSED by the company: Tracy McKibben | Director Elections | Board | ABSTAIN | 1 |
| AIR PRODUCTS AND CHEMICALS INC. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Charles Cogut | Director Elections | Board | ABSTAIN | 1 |
| AIR PRODUCTS AND CHEMICALS INC. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Edward L. Monser | Director Elections | Board | ABSTAIN | 1 |
| AIR PRODUCTS AND CHEMICALS INC. | 2025-01-23 | Election of Directors: Nominees RECOMMENDED by the company: Lisa A. Davis | Director Elections | Board | ABSTAIN | 1 |
← Previous Page 3 of 39 Next →
← Back to Brinker Capital Destinations Trust 2024-2025 overview
Built 2026-10-04 from SEC Form N-PX filings.